arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


|

HEPATITIS B IN IMMIGRANT POPULATIONS: CHALLENGING CASES IN PRIMARY CARE

HEPATITIS B IN IMMIGRANT POPULATIONS:
CHALLENGING CASES IN PRIMARY CARE

Jointly presented by the Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing.

Supported by an educational grant from Bristol-Myers Squibb Company.

OVERVIEW

Hepatitis B virus (HBV) infection is one of the most common infectious diseases worldwide, with an estimated 350 million people chronically infected, many of whom reside in the developing world including the Asian-Pacific region, sub-Saharan Africa, parts of Eastern Europe, and the Middle East. Several studies show that the prevalence rates of HBV in some US areas can actually mirror those of highly endemic regions. Whereas Asian and Pacific Islanders are being screened fairly well for HBV markers in the United States, screening should be expanded to Middle Eastern and Eastern European populations. Furthermore, a better understanding of beliefs about HBV in refugee communities is critical when discussing the implications of test results with patients. This understanding will facilitate completion of immunizations and compliance with prevention strategies and long-term follow-up. Therefore, this case-based online monograph will provide a knowledge source for clinicians to learn the best practices for recognizing, managing, and improving outcomes for diverse cultures with HBV.

GOAL

This educational activity will provide primary care physicians, nurses, nurse practitioners, and physician assistants with up-to-date information about the detection, prevention, and management of patients with HBV.

TARGET AUDIENCE

This activity is designed for primary care physicians, nurses, nurse practitioners, and physician assistants working with Asian and Pacific Islander, Middle Eastern, and African populations. No prerequisites required.

LEARNING OBJECTIVES

Upon the conclusion of this activity, participants will demonstrate the ability to:

  • ASSESS populations at high risk for developing HBV to provide better comprehensive screening and management resources.
  • FORMULATE population-specific interventions that will better articulate treatment goals to patients with chronic HBV infection to remove cultural barriers to care.

The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE activity.

ACCREDITATION STATEMENTS

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

CREDIT DESIGNATION STATEMENTS

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This 1.2 contact hour educational activity is provided by The Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity. Contact hours will be awarded for this educational activity until February 15, 2013.

HOW TO RECEIVE CREDIT OR CONTACT HOURS

After reading this monograph, participants may receive credit or contact hours by completing the CME/CNE test, evaluation, and receiving a score of 70% or higher.

The estimated time to complete this activity: 1 hour.

Release date: February 15, 2011. Expiration date: February 15, 2013.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require a signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Speakers are required to disclose only those relationships that are relevant to their specific presentation.

POLICY ON FACULTY AND PROVIDER DISCLOSURE

It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the educational activity.

STEERING COMMITTEE

Ahmet Gurakar, MD, FACG (Co-Chair)
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Medical Director, Liver Transplantation
Johns Hopkins University School of Medicine
Baltimore, Maryland

Susan L. Humphreys, RN, MS (Co-Chair)
Nurse Manager
Johns Hopkins Hospital Kidney Transplant Program
Comprehensive Transplant Center
Baltimore, Maryland

Jane C. Shivnan, MScN, RN, AOCN (Nurse Planner)
Executive Director
The Institute for Johns Hopkins Nursing
Baltimore, Maryland

Aijaz Ahmed, MD
Associate Professor of Medicine
Division of Hepatology
Stanford University Medical Center
Stanford, California

Daryl Lau, MD, MSc, MPH
Associate Professor of Medicine
Harvard Medical School (HMS)
Director of Translational Liver Research
Beth Israel Deaconess Medical Center, HMS
Boston, Massachusetts

Author/Speaker Disclosures
Dr Gurakar reports receiving honoraria from Schering-Plough Corporation; serving as a consultant for Gilead; and for receiving other financial or material support from BMS for CME activities and mentoring of a fellow (received an award).

Dr Ahmed reports serving as an advisor for Bristol-Myers Squibb Company and Gilead.

Dr Lau reports receiving research grants from Bristol-Myers Squibb Company and a pending research grant from Gilead; and receiving research funding (medication supply only) from Roche Pharmaceuticals and Schering-Plough Corporation.

Planner Disclosures
Dr Gurakar reports receiving honoraria from Schering-Plough Corporation; serving as a Principal Investigator for BMS; serving as a consultant and a regional Board Consultant for Gilead; and for receiving other financial or material support from BMS for CME activities and mentoring of a fellow (received an award).

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

Off-Label Product Discussion

No faculty member has indicated that their content will include information on off-label products.

Non-endorsement of Products

The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

DISCLAIMER

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This case-based online monograph is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

INTERNET CME POLICY

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.

THE INSTITUTE FOR JOHNS HOPKINS NURSING MISSION STATEMENT

The mission of the Institute for Johns Hopkins Nursing is to share the innovations of Johns Hopkins Nursing in practice, education, and research—locally, nationally, and globally.

Our goal in continuing nursing education is to bring you activities that reflect the expertise and creativity of Johns Hopkins Nursing. Our service values are quality, integrity, flexibility, and personal attentiveness. We appreciate your thoughts and welcome your concerns—please feel free to e-mail us: IJHN@son.jhmi.edu.

Please note: This activity is for reference only as credit has expired.

procced to pretest




Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2012 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.